OMCL - OMNICELL, INC.

QQQ $ 445.78 $ 1.00 (0.22 %)

DIA $ 395.62 $ 0.53 (0.13 %)

SPY $ 523.14 $ 0.96 (0.18 %)

TLT $ 90.86 $ 0.25 (0.28 %)

GLD $ 218.12 $ 0.28 (0.13 %)

Previous Close

$ 30.8

Open

$ 31.20

Bid

$ 0.00 x 0

Ask

$ 30.22 x 100

Day's Range

$ 30.06 - $ 31.20

52 Week Range

$ 25.69 - $ 77.14

Volume

465,784

Average Volume

Market Cap

1.41B

Beta (5Y Monthly)

$ 1.00

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-04-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-25-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	10-30-2020	09-30-2020	10-Q
16	07-31-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	02-26-2020	12-31-2019	10-K
19	11-01-2019	09-30-2019	10-Q
20	08-02-2019	06-30-2019	10-Q
21	05-03-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-02-2018	09-30-2018	10-Q
24	08-03-2018	06-30-2018	10-Q
25	05-04-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-03-2017	09-30-2017	10-Q
28	08-04-2017	06-30-2017	10-Q
29	05-05-2017	03-31-2017	10-Q
30	02-28-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	02-26-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	03-30-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Benchmark Reiterates Buy on Omnicell, Main...
05/03/2024 17:17:50

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:OMCL) with a Buy and maintains $38 price target.

Omnicell Reaffirms FY24 Outlook: Adj EPS $...
05/02/2024 11:47:47

The table below summarizes Omnicell's second quarter and full year 2024 guidance outlined above. ...

Omnicell Q2 Outlook: Total Revenues $250M ...
05/02/2024 11:42:09

The table below summarizes Omnicell's second quarter and full year 2024 guidance outlined above. ...

Omnicell Q1 2024 Adj EPS $0.03 Beats $(0.0...
05/02/2024 11:37:08

Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.09) by 1...

Benchmark Reiterates Buy on Omnicell, Main...
04/30/2024 14:02:27

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:OMCL) with a Buy and maintains $38 price target.

Clover Health Appoints Peter Kuipers As Ch...
04/22/2024 20:14:47

Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physicia...

Omnicell Announces XT Amplify, A Multi-Yea...
04/16/2024 20:14:53

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing SystemOmnicell, Inc. (NASDAQ:...

Benchmark Maintains Buy on Omnicell, Lower...
02/09/2024 19:34:36

Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $42 to $38.

Wells Fargo Maintains Equal-Weight on Omni...
02/09/2024 14:30:34

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Equal-Weight and lowers the price target from $...

Omnicell Expects Q1 Revenue of $232M-$242M...
02/08/2024 13:05:44

The table below summarizes Omnicell's 2024 guidance outlined above. Q1 2024 ...

Omnicell Q4 Adj EPS $0.33 Beats $0.15 Esti...
02/08/2024 13:02:09

Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.15 by 120...

Earnings Scheduled For February 8, 2024
02/08/2024 09:43:03

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

Piper Sandler Upgrades Omnicell: Here's Wh...
11/03/2023 17:00:09

Wells Fargo Upgrades Omnicell to Equal-Wei...
11/03/2023 12:04:40

Wells Fargo analyst Stan Berenshteyn upgrades Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight and lowers the price t...

BTIG Downgrades Omnicell to Neutral
11/03/2023 08:39:57

BTIG analyst David Larsen downgrades Omnicell (NASDAQ:OMCL) from Buy to Neutral.

Piper Sandler Upgrades Omnicell to Overwei...
11/03/2023 08:33:15

Piper Sandler analyst Sean Wieland upgrades Omnicell (NASDAQ:OMCL) from Neutral to Overweight and lowers the price target fr...

why-staar-surgical-shares-are-trading-lower-by-around-16-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why STAAR Surgical Shares Are Trading Lowe...
11/02/2023 18:26:27

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was a...

Omnicell Announces Headcount Reduction, Ex...
11/02/2023 12:39:59

RestructuringOmnicell plans to take action as it relates to cost containment across the business, including a headcount reducti...

Omnicell Sees Q4 2023 Revenue $247M-$267M ...
11/02/2023 12:38:56

For the fourth quarter of 2023, the Company expects total revenues to be between $247 million and $267 million. The Company exp...

Omnicell Sees FY23 Bookings $850M-$950M, S...
11/02/2023 12:38:00